Persistent Immunity Following Enders Live, Attenuated Measles-Virus Vaccine Given with Human Immune Globulin
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Findings are presented showing persistent and undiminished immunity against measles for at least a year after administration of live measles-virus vaccine with human immune globulin.
Abstract
PREVIOUS studies by various workers1 2 3 4 5 6 7 8 9 10 11 12 have established the high level of efficacy of the Enders live measles-virus vaccine given alone or in combination with human immune globulin. Such efficacy is expressed in terms both of development of antibody after vaccination and of protection against natural measles in epidemics.One of the important problems that remain is the assessment of durability of immunity after vaccination. This report presents findings showing persistent and undiminished immunity against measles for at least a year after administration of live measles-virus vaccine with human immune globulin.Materials and MethodsClinical Populations and Vaccination ProcedurePrevious reports . . .